SIGA Technologies Inc

Financials

Übersicht Finanzbericht Statistik Dividenden

Mittelzufluss aus laufender Geschäftstätigkeit 71.52 M11.49 M41.61 M94.8 M48.76 M43.47 M 43.47 M Mittelzufluss aus Investitionstätigkeit -15.5 K-50.62 K0-21.69 K-42.45 K-355.01 K -355.01 K Zahlungsströme aus der Finanzierungstätigkeit -114.6 M-26.2 M-45.96 M-43.42 M-43.46 M-43.55 M -43.55 M Freier Cashflow 71.5 M11.44 M41.61 M94.78 M48.72 M43.12 M 43.12 M

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

SIGA

Financials

SIGA Technologies Inc

Nachrichten

Siga Technologies: No News (On BARDA Contract) Not Necessarily Good News (NASDAQ:SIGA)

SIGA Technologies kündigt Sonderdividende von 0,60 US-Dollar pro Aktie an

SIGA Technologies: Jahresgewinn stark, doch Quartalsverlust und volatile Aktie prägen die Bilanz

SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript

Siga Technologies: As Market Waits For MPOXX Purchases, I Remain On The Sidelines (SIGA)

Tesla, Applovin among market cap stock movers on Friday

SIGA Technologies, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SIGA) 2025-11-07

SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript

SIGA Technologies, Inc. (SIGA) Q2 2025 Earnings Call Transcript

3 Healthcare Stocks Paying the Highest Dividends of 2025

Siga Technologies Inc. (SIGA) Stock Falls Amid Market Uptick: What Investors Need to Know

Siga Technologies Inc. (SIGA) Outpaces Stock Market Gains: What You Should Know